Inhalation Sciences AB (publ) presents at Stockholm Corporate Finance 15th Life Science Capital Markets Days
Inhalation Sciences will take part in the Stockholm Corporate Finance 15th Life Science Capital Markets Days on 8 - 9 March 2023 at IVA Conference Center in Stockholm. CEO Manoush Masarrat will present the latest developments and the future of the company on March 9 at 10:00 am.
Stockholm Corporate Finance Stockholm Corporate Finance is organising the Capital Markets Days for the fifteenth consecutive year in collaboration with Financial Hearings and Infront Direkt Studios, an independent part of Nyhetsbyrån Direkt. If you would like to register as a participant for the Capital Markets Day, please use this link , Stockholm Corporate Finance 15e Life Science Seminarium den 8-9 mars 2023 (lyyti.fi)
For more information about Inhalation Sciences, please contact:
Manoush Masarrat, CEO
E-mail: Manoush.masarrat@inhalation.se
Mobile: +46 (0)73 628 9153
About Inhalations Sciences Sweden AB (publ)
Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and Dissolv It® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.
Tags: